Active Surveillance Is a Safe and Acceptable Treatment Alternative in Select D-TGCT

R. Lor Randall, MD, discusses the adequacy of active surveillance for select patients with diffuse-type tenosynovial giant cell tumor.

Related Keywords

California ,United States ,Italy ,Netherlands ,Toronto ,Ontario ,Canada ,Mayo Clinic In Rochester ,Minnesota ,Sacramento ,America ,Los Angeles ,University Of California ,Department Of Orthopaedic Surgery ,National Comprehensive Cancer Network ,David Linn Endowed Chair ,Orthopaedic Surgery ,East Coast ,Mayo Clinic ,R Lor Randall ,D ,